financetom
Business
financetom
/
Business
/
The Descartes Systems Group Screening Technology Adopted by Givaudan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
The Descartes Systems Group Screening Technology Adopted by Givaudan
Oct 6, 2025 9:58 AM

12:31 PM EDT, 10/06/2025 (MT Newswires) -- Descartes Systems Group ( DSGX ) on Monday said international fragrance and beauty company Givaudan adopted its denied party screening technology to automate compliance checks across its global operations.

The system screens Givaudan's business partners in real time against international denied and sanctioned party lists, replacing manual processes that were slower and more prone to error. Descartes' platform is integrated into Givaudan's internal systems, covering regulatory data from major jurisdictions, including the E.U., North America, and the Asia-Pacific region.

With fragrance and beauty operations in more than 160 locations across 52 countries, Givaudan said the move enhances efficiency and strengthens oversight as trade regulations become increasingly complex. "Our collaboration with Givaudan demonstrates how automated compliance tools can empower global organizations to act with greater supply chain agility, transparency, and integrity," said Shabab Wahdatehagh, VP of Global Trade Intelligence.

Descartes shares were last seen up $0.34 to $131.33 on the Toronto Stock Exchange.

Price: 131.38, Change: +0.39, Percent Change: +0.30

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Sangamo Therapeutics Stock Is Soaring
Why Sangamo Therapeutics Stock Is Soaring
Aug 6, 2024
Sangamo Therapeutics, Inc. ( SGMO ) shares are trading higher Tuesday after the company announced it has entered into a license agreement with Genentech to develop intravenously administered genomic medicines for neurodegenerative diseases.  The Details: Sangamo has granted Genentech an exclusive license to its proprietary zinc finger repressors and neurotropic adeno-associated virus (AAV) capsid, STAC-BBB. Under the terms of the...
CSX Likely to See Stable H2 Amid Mixed Conditions, UBS Says
CSX Likely to See Stable H2 Amid Mixed Conditions, UBS Says
Aug 6, 2024
01:38 PM EDT, 08/06/2024 (MT Newswires) -- CSX (CSX) expects a stable second half of the year even though market conditions remain mixed, UBS said in a note emailed Tuesday. The rail freight company reported Q2 EPS of $0.49, beating estimates of $0.48, with a 2.1% volume increase and a 3.6% rise in merchandise yields. Operating expenses of $2.25 billion...
Update: Market Chatter: AGCO Faces Pressure For Board Shakeup From Top Shareholder
Update: Market Chatter: AGCO Faces Pressure For Board Shakeup From Top Shareholder
Aug 6, 2024
01:31 PM EDT, 08/06/2024 (MT Newswires) -- (Updates with additional details and MT Newswires' request for comment) AGCO's ( AGCO ) largest shareholder, Tractors and Farm Equipment, is seeking to replace AGCO ( AGCO ) directors through a consent solicitation process, before their terms are complete at the next annual shareholder meeting, Bloomberg reported Tuesday, citing people familiar with the...
German drugstore chain shuns Teslas over Musk's support for Trump
German drugstore chain shuns Teslas over Musk's support for Trump
Aug 6, 2024
FRANKFURT, Aug 6 (Reuters) - German drugstore chain Rossmann said on Tuesday it would no longer buy Tesla cars for its corporate fleet due to CEO Elon Musk's support for U.S. Republican presidential candidate Donald Trump. The drugstore chain, which is among the largest in Europe, said its decision was with immediate effect and due to what it called an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved